Search
Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: National News

New Challenge Launches to Create Startups Around Promising Cancer-Related, Nanotechnology Inventions

Monday, December 14, 2015  
Share |
The Center for Advancing Innovation (CAI) has launched the Nanotechnology Startup Challenge for Cancer (NSC2). This is the third in a series of startup challenges developed from the partnership between CAI and National Cancer Institute’s Technology Transfer Center following two award-winning competitions, the Breast Cancer Startup Challenge and the Neuro Startup Challenge.

NSC2 is an open innovation competition designed to bring promising cancer nanotechnology inventions to market. These inventions have the potential to make a significant impact on the health of cancer patients and include therapeutics, diagnostics, prognostics and medical devices. Inventions in the challenge originate from the NIH intramural research program as well as the extramural research community. Participating challenge teams may either select from the NIH intramural inventions or bring in an external, commercially viable, cancer-related nanotechnology invention as the basis to compete in NSC2.

The challenge opened for teams to enter starting October 12, 2015 and closes February 12 2016. A requirement to enter is the formation of a multi-disciplinary team that includes individuals with medical/scientific, legal, and business expertise, and a serial entrepreneur. During the challenge, teams will be offered valuable tools for entrepreneurial learning in the ‘business of science’ through a six-month accelerator program as well as the opportunity to interact with world class mentors, advisors and judges.

“After two successful challenges, something that sets the NSC2 a part is the robust, accelerator training program that all winning teams will be able to leverage,” said Rosemarie Truman, Founder and CEO of CAI. “The type of prestigious accelerator model that we are putting into place for the NSC2 is tailored specifically for this challenge, and has been proven to produce “gazelle companies,” a term associated with high-growth, high-impact startups. The support and resources that will be available for the winning teams presents an incredible opportunity for those entering the competition.” Truman added, “In addition, the NSC2 challenge architecture further amplifies the contest paradigm to move an entire scientific field forward rapidly as we are seeking to advance both NIH intramural inventions as well as extramural inventions."

Visit the challenge website for more information.

more Events

9/29/2016
MDMA 2016 Medical Technology Executive Forum

9/29/2016
Women Building Bio: The XX Factor

Premium Members

Membership Software Powered by YourMembership.com®  ::  Legal